We are live on ! Find out more
PM

Platinum Management Portfolio holdings

AUM $16.4M
1-Year Est. Return 30.38%
This Fund
S&P 500
This Quarter Est. Return
-27.85%
1 Year Est. Return
-30.38%
3 Year Est. Return
+9.74%
5 Year Est. Return
10 Year Est. Return
AUM
$16.4M
AUM Growth
+$9.67M
Cap. Flow
+$11.7M
Cap. Flow %
70.99%
Top 10 Hldgs %
100%
Holding
5
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
NAVB
Navidea Biopharmaceuticals Inc.
NAVB
+$11.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 89.52%
2 Energy 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAVB
1
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$14.7M 89.51%
778,797
+606,299
+351% +$11.7M
ECTE
2
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
$1.09M 6.61%
829,183
PED icon
3
PEDEVCO
PED
$157M
$631K 3.84%
17,047
WCST
4
DELISTED
Wecast Network, Inc. Common Stock
WCST
$6K 0.04%
3,015
NSPR icon
5
InspireMD
NSPR
$33M
0

Similar funds

Platinum Management's Q1 2016 Portfolio in Review

As of Q1 2016, Platinum Management held 5 positions worth $16.4M, up 143% from $6.76M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Platinum Management deployed $11.7M of net new capital in Q1 2016, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 68% a quarter earlier, followed by Energy.

  • Platinum Management added most to Navidea Biopharmaceuticals Inc. in Q1 2016, an estimated $11.7M increase.
  • Platinum Management's ten largest holdings make up 100% of its $16.4M portfolio in Q1 2016.
  • Platinum Management opened 0 new positions and closed 0 in Q1 2016.
  • Platinum Management's portfolio value rose 143% quarter-over-quarter to $16.4M.

Based on Platinum Management's 13F filing for Q1 2016, filed 16 May 2016.